← Eichor
Condition: Vaccine Immune Response Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vaccine Immune Response

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Antibiotics and Vaccine Immune Responses Study
Phase 4 · 1 location(s) · South Australian Health and Medical Research Institute · NCT06148025Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Phase 3 · 5 location(s) · Butantan Institute · NCT06891950A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT07596173TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rub
Phase 3 · 22 location(s) · GlaxoSmithKline · NCT06855160Registry of Vaccine Responses in Immune Compromised Patients
Phase N/A · 1 location(s) · Laure Pittet, MD-PhD · NCT06463119Systems Investigation of Vaccine Responses in Aging and Frailty
Phase 2 · 1 location(s) · Yale University · NCT05291676COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
Phase N/A · 1 location(s) · RenJi Hospital · NCT04871932A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 18 location(s) · GlaxoSmithKline · NCT07596199Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07534007HPV Vaccine Reduced Dose
Phase 4 · 1 location(s) · Emory University · NCT06799494VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01132859Vaccine Immunity and Inflammation in the Aging Person Living With HIV
Phase 4 · 1 location(s) · Hennepin Healthcare Research Institute · NCT06514547Intradermal Influenza Vaccination
EARLY_Phase 1 · 1 location(s) · Yale University · NCT06067555A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine,
Phase 3 · 17 location(s) · GlaxoSmithKline · NCT07406360A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants
Phase N/A · 2 location(s) · Arkansas Children's Hospital Research Institute · NCT07422337A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
Phase 3 · 5 location(s) · Pfizer · NCT07543380Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT04276896Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05078905A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Heal
Phase 3 · 6 location(s) · GlaxoSmithKline · NCT06806137Description of the Immune Response to Yellow Fever Vaccination
NA · 1 location(s) · Institut Pasteur · NCT06718127A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to
Phase 3 · 97 location(s) · GlaxoSmithKline · NCT06740630How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia
Phase N/A · 1 location(s) · Centre for Infectious Disease Research in Zambia · NCT07626606Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles
Phase 3 · 44 location(s) · Pfizer · NCT07660198The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NA · 1 location(s) · National Taiwan University Hospital · NCT04970836Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309Vaccine-induced Immunity in Immunocompromised Patients
Phase N/A · 1 location(s) · University of Cologne · NCT06612515
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.